Related Experiment Video
Updated: Feb 12, 2026
Agrobacterium-Mediated Virus-Induced Gene Silencing Assay In Cotton
Published on: August 20, 2011
Constructing a Novel Hypoxia-Inducible Bidirectional shRNA Expression Vector for Simultaneous Gene Silencing in
Bita Javan1,2, Majid Shahbazi1,2,3
11 Department of Molecular Medicine, School of Advanced Technologies in Medicine, Golestan University of Medical Sciences , Gorgan, Iran .
Background:
Nonspecific siRNA expression limits its application in cancer gene therapy. Therefore, a tightly regulated and reversibly inducible RNAi system is required to conditionally control the gene expression. This investigation aims at constructing a hypoxia/colorectal tumor dual-specific bidirectional short hairpin RNA (shRNA) expression vector.
Materials And Methods:
First, carcinoma embryonic antigen (CEA) promoter designed in two directions. Then, pRNA-bipHRE-CEA vector was constructed by insertion of the vascular endothelial growth factor enhancer between two promoters for hypoxic cancer-specific gene expression. To confirm the therapeutic effect of the dual-specific vector, two shRNA oligonucleotides were inserted in the downstream of each promoter. QRT-polymerase chain reaction and western blot assays were performed to estimate the mRNA and protein expression levels.
Results:
Both mRNA and protein levels were significantly reduced (50%-60%) in the hypoxic colorectal cancer-treated cells when compared with the controls.
Conclusion:
The novel bidirectional hypoxia-inducible shRNA expression vector may be efficient in colorectal cancer-specific gene therapy.
Insights
Researchers developed a novel bidirectional short hairpin RNA (shRNA) expression vector for cancer gene therapy. This hypoxia-inducible vector effectively reduces gene expression in colorectal tumors.
Area of Science:
- Molecular Biology
- Cancer Genetics
- Gene Therapy
Background:
- Nonspecific siRNA limits cancer gene therapy applications.
- A regulated and inducible RNAi system is crucial for conditional gene control.
- This study focuses on developing a hypoxia/colorectal tumor dual-specific bidirectional shRNA expression vector.
Purpose of the Study:
- To construct a novel bidirectional shRNA expression vector.
- To achieve hypoxia and colorectal tumor dual-specific gene expression control.
- To evaluate the therapeutic potential of the vector in colorectal cancer.
Main Methods:
- Designed a carcinoma embryonic antigen (CEA) promoter in two directions.
- Constructed the pRNA-bipHRE-CEA vector with a vascular endothelial growth factor enhancer.
- Inserted shRNA oligonucleotides and analyzed mRNA/protein levels via qRT-PCR and Western blot.
Main Results:
- Hypoxia-inducible shRNA expression vector demonstrated significant gene silencing.
- Both mRNA and protein levels were reduced by 50%-60% in treated hypoxic colorectal cancer cells.
- The vector showed specific activity in the targeted cancer cells under hypoxic conditions.
Conclusions:
- The developed bidirectional hypoxia-inducible shRNA vector shows promise for colorectal cancer gene therapy.
- This novel vector offers a regulated approach to gene silencing in cancer.
- The findings suggest potential for improved therapeutic strategies in colorectal cancer treatment.
Related Concept Videos
00:59Gene Therapy
01:42What is Gene Expression?
Gene expression is the process in which DNA directs the synthesis of functional products, that is, proteins. Cells can regulate gene expression at various stages. It allows organisms to generate different cell types and enables cells to adapt to internal and external factors.
Genetic Information Flows from DNA to RNA to Protein
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is made up of nucleotides and proteins consist of amino...
01:36What is Gene Expression?
02:35Chromatin Position Affects Gene Expression
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the...
01:58Cell Specific Gene Expression
02:51mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability